Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7388 p196
18 February 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Diet may not reduce cancer and CV risk

Dietary changes might not reduce the risk of some cancers and cardiovascular disease, according to a recent study.

The Women’s Health Initiative trial involving 48,835 post-menopausal women has examined the risks of breast cancer (JAMA 2006;295:629), colorectal cancer (ibid, p643) and cardiovascular disease (ibid, p655) through a “dietary modification intervention” programme, over an 8.1-year average follow-up period.

The programme aimed to motivate participants — through strategies such as group sessions and self-monitoring techniques — to reduce dietary fat intake and increase consumption of fruit, vegetables and grains. The comparison group received diet-related education material but were asked not to make diet changes actively.

In the intervention group, 0.42 per cent of omen developed invasive breast cancer, compared with 0.45 per cent of controls, representing no significant reduction in risk (hazard ratio 0.91; 95 per cent confidence interval 0.83–1.01). The authors observed nonsignificant trends that, they say, suggest a reduced breast cancer risk with a low-fat dietary pattern, and might be shown to be significant over a greater number of years.

Investigators also found that, compared with controls, the intervention group did not have a significantly reduced risk of colorectal cancer (HR 1.08; 95 per cent CI 0.90–1.29), or cardiovascular disease (HR 0.98; 95 per cent CI 0.92–1.05).

Five a day okay Eating more than five servings of fruit and vegetables per day can protect people from stroke, a meta-analysis concludes (The Lancet 2006;367:320).

The authors found that, compared with individuals who consumed fewer than three fruit and vegetable servings per day, those who ate more than five servings were at significantly less likelihood of both ischaemic and haemorrhagic stroke (pooled relative risk 0.74; 95 per cent confidence interval 0.69–0.79).

Back to Top


©The Pharmaceutical Journal